Safety effectiveness and immunogenicity of heterologous mRNA1273 boost after prime with Ad26COV2S among healthcare workers in South Africa The singlearm openlabel phase 3 SHERPA study

N GarrettT ReddyN Yende-ZumaA TakalaniSimone RichardsonThandeka Moyo-GweteSharlaa Badal-FaesenFaeezah PatelE et al2025-04-12DOAJhttps://hdl.handle.net/10539/44735Safety effectiveness and immunogenicity of heterologous mRNA1273 boost after prime with Ad26COV2S among healthcare workers in South Africa The singlearm openlabel phase 3 SHERPA studyJournal Article